Refractive status and ocular characteristics of preschool children with retinopathy of prematurity after different treatments.

IF 1.8 4区 医学 Q2 OPHTHALMOLOGY
International journal of ophthalmology Pub Date : 2025-07-18 eCollection Date: 2025-01-01 DOI:10.18240/ijo.2025.07.15
Wu-Yang Jiang, Man-Hong Li, Hao Wang, Dong Niu, Yu-Sheng Wang, Zi-Feng Zhang
{"title":"Refractive status and ocular characteristics of preschool children with retinopathy of prematurity after different treatments.","authors":"Wu-Yang Jiang, Man-Hong Li, Hao Wang, Dong Niu, Yu-Sheng Wang, Zi-Feng Zhang","doi":"10.18240/ijo.2025.07.15","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To compare the changes in preschool refractive status, ocular biological parameters, and higher-order aberrations in children with retinopathy of prematurity (ROP) after retinal laser photocoagulation or anti-vascular endothelial growth factor (anti-VEGF) treatment and explore their underlying factors.</p><p><strong>Methods: </strong>This observational study involved 118 eyes of 59 children, aged 3 to 6y, with ROP followed up between March 2023 and October 2024. They were divided into the laser, anti-VEGF, and anti-VEGF+laser groups. The laser group received a single session of laser photocoagulation. The anti-VEGF group received a single anti-VEGF treatment. The anti-VEGF+laser group received a single anti-VEGF treatment after birth followed by supplementary laser treatment within 2wk to 6mo. Ocular biological parameters were measured using IOL Master 700 and Pentacam HR. Right-eye higher-order aberrations were measured using the OPD-Scan III. Best-corrected visual acuities (BCVA), refractive statuses, ocular biological parameters, and higher-order aberrations were assessed and compared. Multiple linear regression analysis was conducted to evaluate the relationships among ocular biological parameters, higher-order aberrations, spherical equivalent (SE), and treatment methods. Pearson's correlation coefficients were used to assess the relationships between the SE and higher-order aberrations.</p><p><strong>Results: </strong>The laser group had a higher incidence of myopia and a lower SE than the anti-VEGF group. The incidence of astigmatism and cylindrical power were significantly lower for the anti-VEGF than for the laser and anti-VEGF+laser groups (<i>P</i><0.05). The anterior corneal surface astigmatism was higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group. The anterior corneal surface K<sub>2</sub> and lens thickness were higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group. The whole-eye higher-order aberration root mean square (RMS) values for the right eye were significantly higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group. The whole-eye trefoil RMS values for the right eye were also significantly higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group (<i>P</i><0.05). Laser treatment was significantly associated with SE, anterior corneal surface curvature and astigmatism, lens thickness, whole-eye high-order aberrations, and whole-eye trefoil (all <i>P</i><0.05).</p><p><strong>Conclusion: </strong>Children with ROP who received laser treatment have higher myopia and astigmatism than those who received anti-VEGF treatment. Children treated with laser or supplementary laser treatment have higher anterior corneal astigmatism, anterior corneal curvature, thicker lenses, whole-eye higher-order aberrations, and whole-eye trefoil. The cause of myopia in children with ROP after laser treatment is increased anterior corneal surface curvature and lens thickness.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 7","pages":"1317-1325"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207292/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.07.15","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To compare the changes in preschool refractive status, ocular biological parameters, and higher-order aberrations in children with retinopathy of prematurity (ROP) after retinal laser photocoagulation or anti-vascular endothelial growth factor (anti-VEGF) treatment and explore their underlying factors.

Methods: This observational study involved 118 eyes of 59 children, aged 3 to 6y, with ROP followed up between March 2023 and October 2024. They were divided into the laser, anti-VEGF, and anti-VEGF+laser groups. The laser group received a single session of laser photocoagulation. The anti-VEGF group received a single anti-VEGF treatment. The anti-VEGF+laser group received a single anti-VEGF treatment after birth followed by supplementary laser treatment within 2wk to 6mo. Ocular biological parameters were measured using IOL Master 700 and Pentacam HR. Right-eye higher-order aberrations were measured using the OPD-Scan III. Best-corrected visual acuities (BCVA), refractive statuses, ocular biological parameters, and higher-order aberrations were assessed and compared. Multiple linear regression analysis was conducted to evaluate the relationships among ocular biological parameters, higher-order aberrations, spherical equivalent (SE), and treatment methods. Pearson's correlation coefficients were used to assess the relationships between the SE and higher-order aberrations.

Results: The laser group had a higher incidence of myopia and a lower SE than the anti-VEGF group. The incidence of astigmatism and cylindrical power were significantly lower for the anti-VEGF than for the laser and anti-VEGF+laser groups (P<0.05). The anterior corneal surface astigmatism was higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group. The anterior corneal surface K2 and lens thickness were higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group. The whole-eye higher-order aberration root mean square (RMS) values for the right eye were significantly higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group. The whole-eye trefoil RMS values for the right eye were also significantly higher for the laser and anti-VEGF+laser groups than for the anti-VEGF group (P<0.05). Laser treatment was significantly associated with SE, anterior corneal surface curvature and astigmatism, lens thickness, whole-eye high-order aberrations, and whole-eye trefoil (all P<0.05).

Conclusion: Children with ROP who received laser treatment have higher myopia and astigmatism than those who received anti-VEGF treatment. Children treated with laser or supplementary laser treatment have higher anterior corneal astigmatism, anterior corneal curvature, thicker lenses, whole-eye higher-order aberrations, and whole-eye trefoil. The cause of myopia in children with ROP after laser treatment is increased anterior corneal surface curvature and lens thickness.

学龄前早产儿视网膜病变儿童不同治疗后的屈光状态及眼部特征。
目的:比较早产儿视网膜病变(ROP)患儿在视网膜激光光凝或抗血管内皮生长因子(anti-VEGF)治疗后学龄前屈光状态、眼部生物学参数和高阶像差的变化,并探讨其影响因素。方法:本观察性研究纳入59例3 ~ 6岁儿童的118只眼,于2023年3月至2024年10月进行ROP随访。分为激光组、抗vegf组和抗vegf +激光组。激光组接受单次激光光凝治疗。抗vegf组给予单次抗vegf治疗。抗vegf +激光组在出生后接受单次抗vegf治疗,并在2周至6个月内进行辅助激光治疗。使用IOL Master 700和Pentacam HR测量眼部生物学参数。使用OPD-Scan III测量右眼高阶像差。评估并比较最佳矫正视力(BCVA)、屈光状态、眼部生物学参数和高阶像差。采用多元线性回归分析评价眼生物学参数、高阶像差、球面等效(SE)和治疗方法之间的关系。使用Pearson相关系数来评估SE与高阶像差之间的关系。结果:激光组近视发生率高于抗vegf组,SE低于抗vegf组。与激光组和抗vegf +激光组相比,抗vegf组的散光发生率和柱面功率明显降低(激光组和抗vegf +激光组的P2和晶状体厚度均高于抗vegf组)。激光组和抗vegf +激光组右眼全眼高阶像差均方根(RMS)值显著高于抗vegf组。激光组和抗vegf +激光组右眼全眼三叶RMS值均显著高于抗vegf组(ppp)。结论:ROP患儿接受激光治疗后近视和散光发生率高于抗vegf组。接受激光或辅助激光治疗的儿童有较高的角膜前散光、角膜前曲率、较厚的晶状体、全眼高阶像差和全眼三叶草。激光治疗后儿童ROP近视的原因是角膜前表面曲率和晶状体厚度增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
7.10%
发文量
3141
审稿时长
4-8 weeks
期刊介绍: · International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online). This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166. IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO); Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering. International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al. Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society). Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press). Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). Associate Editors-in-Chief include: Prof. Ning-Li Wang (President Elect of APAO); Prof. Ke Yao (President of Chinese Ophthalmological Society) ; Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ; Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA); Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society); Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA); Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA). IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles, both basic and clinical papers. Instruction is Welcome Contribution is Welcome Citation is Welcome Cooperation organization International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信